---
title: Halo Pharma vs Pyramid Pharma Services
slug_a: halo-pharma
slug_b: pyramid-pharma-services
site: cdmo
review_signal_gate: closed
canonical_path: /compare/halo-pharma/pyramid-pharma-services
generated_by: BioBM Editorial AI
---

# Halo Pharma vs Pyramid Pharma Services

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Halo Pharma (halo-pharma) is listed for cdmo. Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.

Services: 10. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Pyramid Pharma Services (pyramid-pharma-services) is listed for cdmo. US-based aseptic fill-finish CDMO specializing in parenteral biologics, peptides, and small molecules from development through commercial supply, with formulation, analytical, stability testing, and vial/syringe/cartridge filling capabilities.

Services: 10. Modalities: 3. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.